Metformin Mylan 1000 mg Norge - norsk - Statens legemiddelverk

metformin mylan 1000 mg

mylan ab - metforminhydroklorid - tablett, filmdrasjert - 1000 mg

Metformin Mylan 500 mg Norge - norsk - Statens legemiddelverk

metformin mylan 500 mg

mylan ab - metforminhydroklorid - tablett, filmdrasjert - 500 mg

Metformin Mylan 850 mg Norge - norsk - Statens legemiddelverk

metformin mylan 850 mg

mylan ab - metforminhydroklorid - tablett, filmdrasjert - 850 mg

Biktarvy Den europeiske union - norsk - EMA (European Medicines Agency)

biktarvy

gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarate - hiv-infeksjoner - antivirale midler til systemisk bruk - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (se avsnitt 5.

Metformin Zentiva 1000 mg Norge - norsk - Statens legemiddelverk

metformin zentiva 1000 mg

zentiva k.s. - metforminhydroklorid - tablett, filmdrasjert - 1000 mg

Metformin Zentiva 500 mg Norge - norsk - Statens legemiddelverk

metformin zentiva 500 mg

zentiva k.s. - metforminhydroklorid - tablett, filmdrasjert - 500 mg

Metformin Zentiva 850 mg Norge - norsk - Statens legemiddelverk

metformin zentiva 850 mg

zentiva k.s. - metforminhydroklorid - tablett, filmdrasjert - 850 mg

Sitagliptin / Metformin hydrochloride Mylan Den europeiske union - norsk - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin / Metformin hydrochloride Accord Den europeiske union - norsk - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Metformin Karo Pharma 1000 mg Norge - norsk - Statens legemiddelverk

metformin karo pharma 1000 mg

karo pharma as - metforminhydroklorid - tablett, filmdrasjert - 1000 mg